# Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy

> **NCT03299036** · NA · COMPLETED · sponsor: **National Cheng-Kung University Hospital** · enrollment: 12 (actual)

## Conditions studied

- Cancer of Liver

## Interventions

- **DEVICE:** Taiwan ACE Beads with doxorubicin

## Key facts

- **NCT ID:** NCT03299036
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2018-10-16
- **Final completion:** 2018-10-16
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-10-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03299036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03299036, "Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03299036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*